Moss Genomics Expands Crypto-Focused Treasury Strategy, Acquires 460 ETH
Moss Genomics Inc., a Canadian biotech firm, is doubling down on its decision to integrate cryptocurrencies into its treasury strategy with its new acquisition of 460 ETH at $4,300 per ETH. The company announced the acquisition, alongside a capital raise through private placement, on February 3, 2025, as part of ...